DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology
Severe acute respiratory syndrome coronavirus (SARS-CoV) and the closely
related SARS-CoV-2 are emergent highly pathogenic human respiratory viruses causing
acute lethal disease associated with lung damage and dysregulated inflammatory
responses. SARS-CoV envelope protein (E) is a virulence factor involved in the activation
of various inflammatory pathways. Here, we study the contribution of host miRNAs to
the virulence mediated by E protein. Small RNAseq analysis of infected mouse lungs
identified miRNA-223 as a potential regulator of pulmonary inflammation, since it was
significantly increased in SARS-CoV-WT virulent infection compared to the attenuated
SARS-CoV-DE infection. In vivo inhibition of miRNA-223-3p increased mRNA levels of
pro-inflammatory cytokines and NLRP3 inflammasome, suggesting that during lung
infection, miRNA-223 might contribute to restrict an excessive inflammatory response.
Interestingly, miRNA-223-3p inhibition also increased the levels of the CFTR transporter,
which is involved in edema resolution and was significantly downregulated in the
lungs of mice infected with the virulent SARS-CoV-WT virus. At the histopathological
level, a decrease in the pulmonary edema was observed when miR-223-3p was inhibited,
suggesting that miRNA-223-3p was involved in the regulation of the SARS-CoVinduced
inflammatory pathology. These results indicate that miRNA-223 participates in
the regulation of E protein-mediated inflammatory response during SARS-CoV infection
by targeting different host mRNAs involved in the pulmonary inflammation, and identify
miRNA-223 as a potential therapeutic target in SARS-CoV infection.
IMPORTANCE The SARS-CoV-2 pandemic has emphasized the need to understand the
mechanisms of severe lung inflammatory pathology caused by human deadly coronaviruses
in order to design new antiviral therapies. Here, we identify miRNA-223-3p
as a host miRNA involved in the regulation of lung inflammatory response mediated
by envelope (E) protein during SARS-CoV infection. miRNAs downregulate the
expression of cellular mRNAs and participate in complex networks of mRNA–miRNA
interactions that regulate cellular processes. The inhibition of miRNA-223 in infected
mice by intranasal administration of antisense RNAs led to changes in the expression
of host factors involved in inflammation (cytokines, chemokines, and NLRP3 inflammasome)
and in the resolution of lung edema ion transporter CFTR. These results
confirmed the contribution of miRNA-223 to the regulation of SARS-CoV-induced
pathogenic processes and support the therapeutic potential of inhibiting miRNAs
during coronavirus infection using RNA interference approaches., This work was supported by grants from the Government of Spain (BIO2016-75549-R; PID2019-107001RBI00
AEI/FEDER, UE; SEV 2017-0712 and PIE_INTRAMURAL_LINEA 1-202020E079), CSIC
(PIE_INTRAMURAL -202020E043), the European Zoonotic Anticipation and Preparedness
Initiative (ZAPI) (IMI_JU_115760), the European Commission (H2020-SC1-2019, ISOLDA
Project No. 848166-2), and the U.S. National Institutes of Health (NIH) (2P01AI060699). L.M.
received a fellowship from the Ministry of Science an Innovation of Spain (BIO2010-16705)
and a contract from ZAPI., Peer reviewed